Preparedness of Community Hospital Against COVID-19
Government of Nepal (GoN) imposed a nationwide lockdown on 24th March, 2020 with an effort to limit the spread of novel corona virus which is responsible for corona virus disease (COVID-19). COVID-19 Nepal: Preparedness and Response Plan (NPRP) was implicated on April 2020 which stated Sukraraj Infectious and Tropical Disease Hospital (STIDH) in the capital, Kathmandu has been designated by the GoN as the primary hospital along with Patan Hospital and the Armed Police Forces Hospital in the Kathmandu Valley. The Ministry of Health and Population (MoHP) had requested the 25 hub and satellite hospital networks across the country; designated for managing mass casualty events; to be ready with infection prevention and control measures, and critical care beds where available.
Hospitals with less than 50 beds viz community-based municipality hospitals were left feeble against the surge of the pandemic. Waiting for the aid and support from government was the only option for some hospitals that lacked resources to combat this invisible culprit of global pandemic. However, Nepal Korea Friendship Municipality Hospital (NKFMH) located in Thimi, Bhaktapur determined itself to fight against this pandemic with
limited resources. This hospital not only serves the local community but also patients coming from all over Province 3 due to government insurance facilities provided by this hospital. With interaction and support from the Hospital Director, Mayor of the municipality, Korea International Cooperation Agency (KOICA), Bhaktapur Red Cross, Hospital board, Hospital Staffs, Medical Team, Adminstration, Interpid and locals in the community prompt preparedness action plan was formulated through various meeting at different levels and acted upon.
United Nations Nepal, COVID-19 NEPAL: Preparedness and response plan (NPRP). April 2020. Available from: https://www.who.int/docs/default-source/nepal-documents/novel-coronavirus/covid-19-nepal-preparedness-and-response-plan-(nprp)-draft-april-9.pdf?sfvrsn=808a970a_2
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. PMID: 31986264 DOI: https://doi.org/10.1016/s0140-6736(20)30183-5
Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA. Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China. Emerg Infect Dis. 2020;26:1049-52. PMID: 32053479 DOI: https://doi.org/10.3201/eid2605.200146
Lai X, Wang M, Qin C, Tan L, Ran L, Chen D, et al. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Network Open. 2020;3(5):e209666. PMID: 32437575 PMCID: PMC7243089 DOI: https://dx.doi.org/10.1001/jamanetworkopen.2020.9666
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N England J Med. 2020;382:970-1. PMID: 32003551 DOI: https://dx.doi.org/10.1056/2FNEJMc2001468
Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020;323(16):1610-1612. PMID: 32129805 DOI: https://doi.org/10.1001/jama.2020.3227
US Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019- nCoV) or Patients Under Investigation for SARS-CoV-2 in Healthcare Settings. Atlanta, GA: US Centers for Disease Control and Prevention, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
Copyright (c) 2020 Ijendra Prajapati
This work is licensed under a Creative Commons Attribution 4.0 International License.
- The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- JLMC requires an exclusive licence to publish the article first in its journal in print and online.
- The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
- License agreement
- In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
- I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
Please visit Creative Commons web page for details of the terms.